Benefit of Abciximab in Patients with Refractory Unstable Angina in Relation to Serum Troponin T Levels

Abstract

The serum troponin T level, which is considered to be a surrogate marker for thrombus formation, identifies a high-risk subgroup of patients with refractory unstable angina suitable for coronary angioplasty who will particularly benefit from antiplatelet treatment with abciximab.